The biotech company's shares surged after announcing an ambitious plan for its sublingual drug delivery technology and boosting its 2026 financial outlook.
The non-dilutive capital is aimed at advancing the company's battery manufacturing capabilities and bolstering its position in the U.S. supply chain.
All-stock deal aims to create a diversified semiconductor equipment leader, though Axcelis shares dip on the news.
Autonomous trucking firm's shares rose 2.2% in after-hours trading after the billionaire's fund disclosed a 5.7% passive investment.
A multibillion-dollar AI agreement is in limbo as the US Commerce Department scrutinizes the UAE's ties to Beijing, potentially impacting Nvidia's growth.
The recently-listed Hong Kong construction firm's shares plummeted to all-time lows, triggering multiple volatility halts amid a lack of news.
The battery manufacturer secured a key grant to modernize its production facilities and expand workforce development programs.
The move pressures credit bureaus, with competitors TransUnion and Equifax seeing their stock prices fall sharply in response.